Sphingomyelin phosphodiesterase

From WikiMD's WELLNESSPEDIA

Structure of sphingomyelin phosphodiesterase.

Sphingomyelin phosphodiesterase (also known as sphingomyelinase) is an enzyme that catalyzes the hydrolysis of sphingomyelin to produce ceramide and phosphocholine. This enzyme plays a crucial role in the sphingolipid metabolism pathway and is involved in various cellular processes, including signal transduction, apoptosis, and cell differentiation.

Function[edit]

Sphingomyelin phosphodiesterase is responsible for the breakdown of sphingomyelin, a type of sphingolipid found in cell membranes. The enzyme cleaves the phosphodiester bond in sphingomyelin, resulting in the formation of ceramide, a bioactive lipid that acts as a second messenger in several signaling pathways.

Types[edit]

There are several types of sphingomyelin phosphodiesterases, which are classified based on their pH optima and cellular localization:

Mechanism[edit]

The enzymatic mechanism of sphingomyelin phosphodiesterase involves the coordination of a metal ion at the active site, which facilitates the hydrolysis of the phosphodiester bond. The enzyme undergoes a conformational change upon substrate binding, allowing the catalytic residues to interact with the substrate and promote the cleavage reaction.


Clinical Significance[edit]

Mutations in the gene encoding acid sphingomyelinase lead to Niemann-Pick disease, a group of inherited metabolic disorders characterized by the accumulation of sphingomyelin in various tissues. This results in hepatosplenomegaly, neurological dysfunction, and other systemic symptoms.

Related Enzymes[edit]

Sphingomyelin phosphodiesterase is part of a larger family of phosphodiesterases that includes enzymes such as phospholipase C and phospholipase D, which also play roles in lipid metabolism and signaling.

Related Pages[edit]

Mechanism of sphingomyelinase action.

See Also[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.